| Net Cash Provided by (Used in) Operating Activities |
$162,155 |
USD |
-32% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$86,512 |
USD |
-6.3% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,800,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
38,504,003 |
shares |
1.5% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$605,052 |
USD |
226% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$15,783 |
USD |
3.6% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,185,082 |
USD |
0% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$2,185,082 |
USD |
0% |
Q3 2025 |
FY 2025 |
| Depreciation |
$8,196 |
USD |
65% |
Q3 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$57,217 |
USD |
23% |
Q3 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.055 |
pure |
0% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,537,366 |
USD |
0% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$1,324 |
USD |
14% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
FY 2025 |
| Interest Expense |
$1,313 |
USD |
-104% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |